Article thumbnail

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

By James S. Ferriss, James J. Java, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Joan L. Walker, Howard D. Homesley, Jeffrey Fowler, Benjamin E. Greer, Matthew P. Boente and Robert A. Burger
Publisher: Elsevier BV
Year: 2015
DOI identifier: 10.1016/j.ygyno.2015.07.103
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles